ACL Subsidiary SunDoctors Hit by Contained Cyber Incident via External IT Provider

Australian Clinical Labs Ltd ( (AU:ACL) ) just unveiled an announcement.

Australian Clinical Labs has disclosed that an external IT service provider used by its SunDoctors subsidiary suffered a cyber incident, allowing unauthorised access to a limited part of SunDoctors’ systems and briefly disrupting its practices and operations. The issue has been contained, systems have been restored, and third-party cybersecurity experts have been engaged while SunDoctors investigates any potential impact on sensitive personal information and stands ready to notify affected individuals and regulators.

The company has informed national cybersecurity and privacy authorities and will provide further updates if there are material developments, while stressing that its core laboratory systems and broader ACL operations remain unaffected by the breach. The incident underscores the cybersecurity risks associated with third-party technology providers but, based on current information, appears operationally contained to SunDoctors’ environment, limiting immediate disruption for patients, referrers, and investors.

The most recent analyst rating on (AU:ACL) stock is a Hold with a A$2.20 price target. To see the full list of analyst forecasts on Australian Clinical Labs Ltd stock, see the AU:ACL Stock Forecast page.

More about Australian Clinical Labs Ltd

Australian Clinical Labs Limited is an Australian pathology and diagnostic services provider, with operations including its SunDoctors subsidiary focused on skin cancer and related clinical services. The group operates laboratory and clinical practices across Australia, supporting healthcare providers and patients with testing and specialist medical services.

Average Trading Volume: 856,990

Technical Sentiment Signal: Sell

Current Market Cap: A$364.1M

Find detailed analytics on ACL stock on TipRanks’ Stock Analysis page.